CNRS Technologies

Find the best CNRS technologies to boost your innovative project.

Newest patents

You are a research scientist?

We can guide you through the whole technology transfer process.

See all our services

You are a corporate player?

Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.

Contact us

Follow our news and upcoming events

Discover CNRS technologies

Meet our team

Close

Synthesis of sea precursors

Reference

85777-01

Patents status

French patent application FR0305569 filed on May 7, 2003 entitled “Synthesis of substituted heterocyclic compounds”

Inventors

Ali AL-MOURABIT
Nathalie TRAVERT
Said GHOULAMI
Robert ABOU-JNEID

commercial status

Exclusive or non-exclusive licenses and collaborative research

Laboratory

Institut de Chimie des Substances Naturelles (ICSN), a CNRS laboratory, UPR 2301, in Gif-sur-Yvette, France.

Description

CONTEXT

It is known that compounds of following molecular structure in which A et B are heteroatoms and R is a substituent can be used for the synthesis of precursors of numerous natural products having properties of great interest, in particular in the pharmaceutical field, especially for the synthesis of alkaloids of marin origin, of azugar derivatives and of analogs of these products.

TECHNICAL DESCRIPTION

This invention provides a process for the production of these 5 membered heterocycles comprising two heteroatoms which are substituted, simple, cheap and with good yield, by opening biheterocycles of following structures.

INDUSTRIAL APPLICATIONS

– Rapid synthesis of natural precursors , for example of alkaloids of marine origin, such as hymenidin, chlathrodin and oroidin;

– New synthetic route for biogenetic precursors of products having therapeutic properties of great interest, in particular exhibiting immunosuppressant, antitumoral, antimicrobial and antiviral activities or also anticraving activity.

For further information, please contact us (Ref 85777-01)


Need further information ?

Contact us
Close

Contact us

  • This field is for validation purposes and should be left unchanged.
Close

Newest patents